Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210227050512N1Phase 3Completed
Phase 3 trial of nanocalcium hydroxide in pulpal necrosis, sponsored by Shiraz University of Medical Sciences. Started Sep 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210227050512N1.